Drug Type Small molecule drug |
Synonyms GSK3/HDAC6 dual inhibitors(The First Affiliated Hospital of Xi'an Jiaotong University) |
Target |
Action inhibitors |
Mechanism GSK-3 inhibitors(Glycogen synthase kinase-3 inhibitors), HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 23 Feb 2026 | |
| Neoplasms | Preclinical | China | 23 Feb 2026 |





